“Don’t be afraid” should be the take home message for attendees of this session. Dermatologists need to make sure they are current in the correct and potential uses of the latest systemic therapies. Clinicians of all levels of training and practice setting need to optimize therapeutic regimens for patients with aggressive and challenging disorders as well as routine conditions, or risk losing these patients to other specialists that are “not afraid.” As the understanding of immune system pathways, cytokine balances, and cellular interactions continues to expand, so must the potential applications of systemic therapies. Our current therapeutic regimens are only as efficacious as our comfort with their utilities, which can only begin with matching the mechanisms of action as well as the safety profiles. Many newer agents have evolved from experimental and conceptual to readily available therapeutic modalities. The goals of this session are to review fundamentals of systemic therapeutics including appropriate dosage strategies, laboratory monitoring, and most importantly to explore various disease classifications within dermatology where systemic approaches are necessary.
This activity has been approved by the American Board of Dermatology (ABD) for up to 30 MOC Component 2 Self-Assessment credits. For more information about MOC, please visit the ABD website at www.abderm.org.
Dr. Bhatia / Introduction and Housekeeping
Dr. Kaufmann / Costs of systemic drugs in Dermatology: obstacles and issues
Dr. Del Rosso / Systemic therapies made simple for Dermatologists
Dr. Murase / Using systemic therapies during pregnancy
Dr. Bhatia, Dr. Kaufmann, Dr. Del Rosso, and Dr. Murase / Panel Discussion and Audience Questions
Dr. Pariser / Systemic therapies for Psoriasis and beyond
Dr. Kircik / Who’s afraid of big bad biologics?
Dr. King / Brett King—Do you know JAK? JAK inhibitors in dermatology
Dr. Bhatia, Dr. Pariser, Dr. King, and Dr. Kircik / Panel Discussion and Audience Questions
Dr. Patel / Systemic Therapies for Medical Oncology
Dr. Tomecki / Advances in ID Rx: Real and Imagined
Dr. Lio / Safety of Systemic Therapies in Pediatric Dermatology
Dr. Lio, Dr. Bhatia, Dr. Patel, and Dr. Tomecki / Panel Discussion and Audience Questions
All faculty / Session Adjourns